7Kieffer TL, Sarrazin C, Miller JS, et al. Telaprevir and pegylated interferon-alpha-2a inhibit wildtype and resistant genotype 1 hepatitis C virus replication in patients[J]. Hepatology,2007,46(3):631-639.
8Sarrazin C, Rouzier R, Wagner F, et al. SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders[J]. Gastroenterology, 2007,132(4): 1270-1278.
9Anonymous. Combination therapy with HCV protease inhibitor boceprevir produces a high rate of early virological response in genotype 1 hepatitis C patients[EB/OL].[2008- 01-09 ]. http ://www. hivandh epatitis. com/hep_c/news/2007/102307_a.html.
10Baker R. Experimental Roche polymerase inhibitor R1626 shows robust synergistic effect in combination with pegylated interferon with or without ribavirin[C/OL]//58th Annual Meeting of the American Association for the Study of Liver Diseases,Boston,USA,November 2-6,2007. [2008-01-07].http : //www. hivandhepatitis. com/2007icr/aasld/docs/110607_b. html.
